期刊文献+

支气管哮喘患者血清IL-6、TNF-α、IgE检测的临床分析 被引量:47

Clinical Study on Serum IL-6,TNF-α and IgE Contents in Patients with Bronchial Asthma
下载PDF
导出
摘要 目的:探讨对支气管哮喘患者进行白细胞介素6(IL-6)、肿瘤坏死因子α(TNF-α)、IgE检测的临床意义。方法:通过观察36例急性支气管哮喘发作期患者(哮喘组)治疗前后血清IL-6、TNF-α、IgE含量的动态变化,并与健康体检者(对照组)比较。结果:哮喘组哮喘发作期患者血清IL-6、TNF-α、IgE含量均明显高于对照组(均P<0.01);哮喘缓解后即刻IL-6、TNF-α、IgE含量均较哮喘发作期有明显下降(均P<0.01);哮喘缓解后14d,IL-6、TNF-α、IgE含量较哮喘缓解后即刻又有明显下降(均P<0.01),但仍较对照组高(均P<0.05)。IL-6、TNF-α含量和IgE含量均呈正相关(r=0.618,P<0.01;r=0.723,P<0.01)。结论:支气管哮喘病情的严重程度与IL-6、TNF-α、IgE含量密切相关,临床可以通过检测IL-6、TNF-α、IgE的含量作为判断支气管哮喘病情严重程度和治疗效果的重要指标。 Objective To study the clinical significance of detecting serum interleukin-6(IL-6),tumor necrosis factor-α(TNF-α) and IgE contents in patients with bronchial asthma.Methods Serum IL-6,TNF-α and IgE contents were measured with ELISA in 36 patients with bronchial asthma both during acute attack and after treatment(immediate after remission and 14 days later) as well as in 30 controls.Results The serum contents of IL-6,TNF-α and IgE in patients during asthma attack were significantly higher than those in controls(all P0.01).The levels were significantly decreased immediately after asthma relief(all P0.01),and then further decreased after 14d(all P0.01),but still remained higher than those of controls(P0.05).Significantly positive correlationship was observed between IL-6,TNF-α and IgE levels(r=0.618,P0.01,r=0.723,P0.01).Conclusion The severity of bronchial asthma is closely related to serum IL-6,TNF-α and IgE content.Therefore,clinical detection of IL-6,TNF-α and IgE levels was useful for assessment of the therapeutic efficacy.
出处 《放射免疫学杂志》 CAS 2010年第1期64-66,共3页 Journal of Radioimmanology
  • 相关文献

参考文献6

二级参考文献27

  • 1李立文.粒细胞巨噬细胞集落刺激因子与哮喘非特异性炎症[J].国外医学(呼吸系统分册),1994,14(1):21-24. 被引量:11
  • 2牛丽丽.肿瘤坏死因子与冠心病[J].国外医学(心血管疾病分册),1994,21(6):323-325. 被引量:28
  • 3张国安.肿瘤坏死因子的研究进展[J].中国实验临床免疫学杂志,1989,1(5):43-45. 被引量:33
  • 4DOHERTY T, BROIDE D. Cytokines and growth factors in air- way remodeling in asthma[J]. Curr Opin Immunol, 2007, 19(6): 676-680.
  • 5BRIGHTLING C, BERRY M, AMRANI Y. Targeting TNF-alpha: a novel therapeutic approach for asthma [J]. J Allergy Clin Immunol, 2008, 121(1): 5-10.
  • 6BERRY M, BRIGHTLING C, PAVORD I, et al. TNF-alpha in asthma[J]. Curt Opin Pharmacol, 2007, 7(3): 279-282.
  • 7DALDEGAN MB, TEIXEIRA MM, TALVANI A, et al. Concentration of CCLll, CXCL8 and TNF-alpha in sputum and plasma of patients undergoing asthma or chronic obstructive pulmonary disease exacerbation[J]. Braz J Med Biol Res, 2005, 38 (9): 1359-1365.
  • 8VON GARNIER C, WIKSTROM ME, ZOSKY G, et al. Allergic airways disease develops after an increase in allergen capture and processing in the airway mucosa[J]. J Immunol, 2007, 179 (9): 5748-5759.
  • 9M. LAMPINEN, M. CARl.SON, L. D. HAKANSSON, et al. Cytokine-regulated accumulation of eosinophils in inflammatory disease[J]. Allergy, 2004, 59(8): 793-805.
  • 10BARNES PJ. Immunology of asthma and chronic obstructive pulmonary disease[J]. Nat Rev Immunol, 2008, 8(3): 183-192.

共引文献3595

同被引文献466

引证文献47

二级引证文献488

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部